Home > Financial Ratios > MARKSANS PHARMA

MARKSANS PHARMA
Working Capital/Sales

    Back to All Ratios
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Working Capital/Sales(x) 1.381.591.551.531.83

What is the latest Working Capital/Sales ratio of MARKSANS PHARMA ?

The latest Working Capital/Sales ratio of MARKSANS PHARMA is 1.38 based on Mar2026 Consolidated results.
Year Working Capital/Sales
Mar20261.38
Mar20251.59
Mar20241.55
Mar20231.53
Mar20221.83

How is Working Capital/Sales of MARKSANS PHARMA Trending?

Years Working Capital/Sales % Change
Mar2026 1.38
-13.21
Mar2025 1.59
2.58
Mar2024 1.55
1.31
Mar2023 1.53
-16.39
Mar2022 1.83 -

Other Financial Ratios of MARKSANS PHARMA


Compare Working Capital/Sales ratio of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹13,480.4 Cr -4.4% -5% 74.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,684.0 Cr -1.4% -6.5% 5.5% Stock Analytics
DIVIS LABORATORIES ₹242,904.0 Cr -2% -2.7% 40.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹172,213.0 Cr -1.8% -7% 29.6% Stock Analytics
CIPLA ₹106,138.0 Cr 0.1% -3% -15.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,304.0 Cr 0.2% 6% -2.4% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-4.4%

-5%

74.9%

SENSEX

0.9%

-0.8%

-10.5%


You may also like the below Video Courses